Longitudinal reduction of quality of life in patients with epilepsy and no seizure increase during the COVID-19 pandemic
|Longitudinal reduction of quality of life in patients with epilepsy and no seizure increase during the COVID-19 pandemic
|Year of Publication
|Gonzalez-Martinez, A., Á. Planchuelo-Gómez, A. Vieira, F. Martínez-Dubarbie, J. Vivancos, and M. De Toledo
|7th Congress of the European Academy of Neurology
Background and aims: In early 2020, the novel coronavirus disease (COVID-19) pandemic has impaired medical care of chronic neurological diseases, including epilepsy. The objective of this study is to evaluate the impact of the COVID-19 pandemic in the levels of anxiety, depression, somnolence and quality of life using validated scales in patients with epilepsy in real-life clinical practice.